💥 Ivonescimab, bi-specific PD-1/VEGF, hits a 4th positive Phase III randomized clinical trial, first outside lung cancer indications already approved in China.
✅ 1 L Biliary-tract carcinoma: Ivo + chemo >> Durva + chemo, better ORR, PFS, and OS
#ESMO26